Navigation Links
Dartmouth study provides first global evidence that foreign aid boosts public opinion
Date:2/11/2014

rk; or aid may be seen as helping to prop up dysfunctional or repressive regimes.

The few empirical studies conducted have had methodological limitations and produced mixed results, with some showing at least a temporary boost in public opinion, while others show no widespread, long-lasting effect. But the Dartmouth-Australian study takes a new approach to the issue, applying for the first time a comparative, cross-national perspective using data from a variety of countries. The results suggest that in addition to its humanitarian benefits, foreign aid that meets certain criteria -- targeted at important needs, sustained over time, perceived as being effective, and highly visible -- can serve an important strategic goal for those countries that give it.


'/>"/>

Contact: John Cramer
John.Cramer@Dartmouth.edu
603-646-9130
Dartmouth College
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Dartmouth researcher finds novel genetic patterns that make us rethink biology and individuality
2. Clemson, Dartmouth use $1.5M grant to develop mobile health technology
3. Dartmouth researchers receive $5.9 million grant from NIH for lung research
4. Dartmouth researchers develop molecular switch that changes liquid crystal colors
5. Dartmouth researchers test safety of Nivolumab in kidney cancer
6. Leap in leukemia treatment reported by Dartmouth researchers
7. Dartmouth medical research closes in on new tuberculosis vaccine
8. Mayo Clinic, Dartmouth-Hitchcock announce collaboration
9. Dartmouth researchers investigate the cognitive effects of athlete head impacts
10. Study: Resilience in parents of children undergoing stem cell transplant
11. Grant supports Cedars-Sinai study of possible links between air pollution and brain cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Dartmouth study provides first global evidence that foreign aid boosts public opinion
(Date:3/5/2015)... In recognition of its ongoing commitment ... Flordis International (SFI) has been honored by the American ... natural medicine company committed to identifying and developing natural ... and effectiveness. For these efforts the non-profit ABC selected ... in Phytomedicinal Research Award. , Phytomedicinal research seeks ...
(Date:3/5/2015)... Building on its commitment to provide oncology ... Academy of Oncology Nurse & Patient Navigators (AONN+) has ... ™ (CONQUER ™). , “Cancer has become ... their loved ones each year,” says Pam Rattananont Ferris, ... there is a need in the oncology space for ...
(Date:3/5/2015)... Hinton, W.Va. (PRWEB) March 05, 2015 ... looming, but rather here—and it’s a crisis that is ... , In order to stay on top of ... are partnering with PracticeLink to meet face-to-face with physicians ... Career Advancement Workshop and Job Fair series. , Physician ...
(Date:3/4/2015)... UK (PRWEB) March 05, 2015 ... clinical therapeutics landscape over the past decade. The ... carriers for drug delivery in the form of ... delivering manifold drugs with more safety and efficiency. ... nanoparticles could perhaps rely greatly upon the enhanced ...
(Date:3/4/2015)... (PRWEB) March 05, 2015 The ... a value of $5,632.8 million by 2019, at ... of 2014 to 2019. , Browse through the ... analysis of industry trends and segments, with the ... , Phthalic Anhydride (PA) is a derivative ...
Breaking Medicine News(10 mins):Health News:SFI Receives Prestigious ABC’s Tyler Award Given For Global Research Effort 2Health News:SFI Receives Prestigious ABC’s Tyler Award Given For Global Research Effort 3Health News:The Academy of Oncology Nurse & Patient Navigators Launches CONQUER: the patient voice™ to Help Meet the Informational Needs of Patients with Cancer 2Health News:Physician Shortage Crisis Worsening 2Health News:Cancer Nanomedicine Marketplace Discussed by Kuick Research in Topical Study Recently Published at MarketPublishers.com 2Health News:Cancer Nanomedicine Marketplace Discussed by Kuick Research in Topical Study Recently Published at MarketPublishers.com 3Health News:The Asia-Pacific Ohthalic Anhydride Market is Estimated to Reach $5,632.8 Million by 2019 - A Report by MicroMarket Monitor 2Health News:The Asia-Pacific Ohthalic Anhydride Market is Estimated to Reach $5,632.8 Million by 2019 - A Report by MicroMarket Monitor 3
... of California, Los Angeles say that certain compounds found in ... The scientists found that two compounds found in plant roots ... is responsible for tooth decay. ,This plant root ... study are to appear in the Feb. 24 print version ...
... of life of patients suffering from Motor Neurone Disease (MND), ... use of a simple ventilator and facemask//. ,Patients ... new technique called non-invasive ventilation (NIV). It works by helping ... muscles, the online edition of BBC News reported. ...
... company, Schering, has obtained promising results in the development ... contraceptive, which comes almost 45 years after Schering developed ... in the form of an implanted hormonal capsule and ... project is headed by a slightly-built 53-year-old woman, Professor ...
... 250,000 early-stage glaucoma patients risk blindness due to lack of ... National Institute for the Blind (RNIB).// In an attempt to ... has been launched in the UK. ,Apart from ... from some form of visual impairment in the UK. The ...
... drugs which were found to be an effective anti-depressant ... the researchers are not sure about the mechanism of ... ,Assistant Professor Gerard Aherm and team from Georgetown University ... Inhibitors) which has been found to be an effective ...
... from Northwestern University, Feinberg School of Medicine have found ... to inhibit the production of the immune cells Cytokines ... for causing inflammation in brain cells leading to neuron ... disease. ,Alzheimer’s disease is characterized by loss ...
Cached Medicine News:Health News:Male Contraceptive Pill Being Developed By Berlin Pharmaceutical 2
(Date:3/4/2015)... , March 4, 2015 The March 3, 2015, ... testosterone drugs must change their products, labels to clarify the ... heart attack and stroke is necessary to protect the public ... , a partner at Simmons Hanly Conroy . ... on labels that the products – currently taken by millions ...
(Date:3/4/2015)... 2015 UPM Pharmaceuticals, a division of Gregory ... Pharmaceuticals to manufacture Flibanserin 100 mg tablets. Sprout has ... first drug approved to treat hypoactive sexual desire disorder ... The tablets will be manufactured at UPM,s ... . Dr. John M. Gregory ...
(Date:3/4/2015)... , March 4, 2015 From March ... the 2015 Distribution Management Conference and Expo in ... is HDMA,s largest supply chain education event, attended ... parties who keep the pharmaceutical distribution industry moving. ... regulatory and legislative issues important to healthcare distribution ...
Breaking Medicine Technology:Simmons Hanly Conroy, LLC: FDA Orders Label Warnings on Testosterone Drugs Concerning Normal Aging Use and Heart Attack-Stroke Risks 2UPM Pharmaceuticals to Manufacture Sprout Pharmaceuticals' Flibanserin Tablets 2UPM Pharmaceuticals to Manufacture Sprout Pharmaceuticals' Flibanserin Tablets 3
... Pharmaceuticals, Inc. (NYSE: WPI ) today ... an Abbreviated New Drug Application (ANDA) with the ... to market Norethindrone Acetate/Ethinyl Estradiol and Ethinyl Estradiol and ... 75 mg. Watson,s ANDA product is a generic ...
... a leading biopharmaceutical company dedicated to the research and ... immunological disorders, is marking Digestive Disease Week (DDW) 2012 ... the lives of patients with Crohn,s disease. UCB will ... "DDW is an exciting opportunity for UCB ...
Cached Medicine Technology:Watson Confirms Lo Loestrin® Fe Patent Challenge 2Watson Confirms Lo Loestrin® Fe Patent Challenge 3UCB Proudly Reinforces Long-Standing Commitment to Crohn's Disease Community at Digestive Disease Week 2012 2UCB Proudly Reinforces Long-Standing Commitment to Crohn's Disease Community at Digestive Disease Week 2012 3UCB Proudly Reinforces Long-Standing Commitment to Crohn's Disease Community at Digestive Disease Week 2012 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: